Company Name:Aptinyx, Inc.
CEO: Norbert G. Riedel

Sector: Health Services

Exchange: NASDAQ

Country: US

Description: Aptinyx Inc. is a clinical stage biopharmaceutical company. It engages in the discovery, development, and and commercialization of transformative therapies for disorders of the brain and nervous system. Its product includes NYX-2925, NYX-783, NYX-458, and the AGN-241751 program. The company was founded by Norbert G. Riedel and Joseph R. Moskal in June 2015 and is headquartered in Evanston, IL.

Key numbers

Market Capitalization:168469164
Shares Outstanding: 45655600
Float: 22185426
Next Earning Date:2020-08-17
TTm EPS: -1.5463
TTm Dividend Rate:
200 days moving average:3.48
50 days moving average: 4.16
One day percent Change: 4.77

2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2016-12-31, 2017-12-31, 2018-12-31,
2016-12-31, 2017-12-31, 2018-12-31,